COURTNEY LEMMING SUMMERS: Open Payments
NPI 1932574787 · WINDERMERE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,529 in 77 payments from 17 companies in 2025. Trend: 2023 $1,616 · 2024 $1,555 · 2025 $1,529
Food & beverage: $1,529
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $336 |
| ABBVIE INC. | 15 | $247 |
| Novo Nordisk Inc | 11 | $217 |
| PFIZER INC. | 8 | $140 |
| Exact Sciences Corporation | 6 | $136 |
| Merck Sharp & Dohme LLC | 4 | $94 |
| GlaxoSmithKline, LLC. | 4 | $79 |
| Astellas Pharma US Inc | 3 | $60 |
| Abbott Laboratories | 2 | $49 |
| Amgen Inc. | 2 | $37 |
Products named: QULIPTA, FARXIGA, Wegovy, BREZTRI, GARDASIL 9, The Cologuard Plus Collection Kit, NURTEC ODT, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
